Matrix USA Rating Changes 7/17
More News related to CPB
- Campbell Soup Company Announces the Webcast of Its Year-End Results
- Campbell Soup (CPB) Appoints Owens as Senior VP/CFO
- Campbell Names B. Craig Owens Chief Financial Officer and Chief Administrative Officer
- Campbell's(R) Chunky(TM) Soup and NFL Moms Team Up to Tackle Hunger Nationwide
- LaDainian Tomlinson's personal behind the scenes footage from the 2008 Campbell's Chunky soup "Working Day" ad shoot
More News related to ELMG
- Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles
- EMS Technologies to Present At the 4th Annual Noble Financial Equity Conference in Las Vegas Aug. 18
- EMS Technologies Announces Expansion of Stock Repurchase Program
- EMS Technologies (ELMG) Appoints Mackay as COO/VP
- EMS Technologies Appoints Neil Mackay Chief Operating Officer and EVP
More News related to GSK
- Valeant Pharmaceuticals (VRX) and GlaxoSmithKline Enter Collaboration for Retigabine
- GlaxoSmithKline To Post Quarterly US Grants Report
- New Study Suggests Increasing Prescription Co-payments for Chronic Diseases May Worsen Health Disparities, Adversely Affect Health
- Warren Buffett Accumulates NRG Energy (NRG) Stock; Raises Stakes in Ingersoll-Rand (IR) and Union Pacific (UNP)
- GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season
Upgrades:
Total System Services (NYSE: TSS) from Hold to Buy; Medis Technologies (Nasdaq: MDTL) from Hold to Buy; EMS Technologies (Nasdaq: ELMG) from Hold to Buy; Net 1 UEPS Technologies (Nasdaq: UEPS) from Sell to Hold; Stamps.com (Nasdaq: STMP) from Strong Sell to Hold;
Downgrades:
SiRF Technology Holdings (Nasdaq: SIRF) from Buy to Hold; Perot Systems (NYSE: PER) from Buy to Hold; GlaxoSmithKline (NYSE: GSK) from Buy to Hold; Standex Int'l (NYSE: SXI) from Buy to Hold; Campbell Soup Company (NYSE: CPB) from Strong Buy to Sell;
Related Categories
DowngradesUpgrades
Stocks Mentioned
-0.56
+0.03Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
